These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3582167)

  • 1. Assessment of specific drug disorders in a sample of substance abuse patients: a comparison of the DIS and the SADS-L procedures.
    Hasin DS; Grant BF
    Drug Alcohol Depend; 1987 Mar; 19(2):165-76. PubMed ID: 3582167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric diagnosis of patients with substance abuse problems: a comparison of two procedures, the DIS and the SADS-L. Alcoholism, drug abuse/dependence, anxiety disorders and antisocial personality disorder.
    Hasin DS; Grant BF
    J Psychiatr Res; 1987; 21(1):7-22. PubMed ID: 3560008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing depressive disorders in patients with alcohol and drug problems: a comparison of the SADS-L and the DIS.
    Hasin DS; Grant BF
    J Psychiatr Res; 1987; 21(3):301-11. PubMed ID: 3681764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
    Gillespie NA; Neale MC; Prescott CA; Aggen SH; Kendler KS
    Addiction; 2007 Jun; 102(6):920-30. PubMed ID: 17523987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN.
    Compton WM; Cottler LB; Dorsey KB; Spitznagel EL; Mager DE
    Drug Alcohol Depend; 1996 Jul; 41(3):179-87. PubMed ID: 8842630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents.
    Chung T; Martin CS
    J Consult Clin Psychol; 2005 Dec; 73(6):995-1004. PubMed ID: 16392973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability of the CIDI-SAM: a comprehensive substance abuse interview.
    Cottler LB; Robins LN; Helzer JE
    Br J Addict; 1989 Jul; 84(7):801-14. PubMed ID: 2758153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance-use disorders in DSM-III-R. Evidence for the dependence syndrome across different psychoactive substances.
    Kosten TR; Rounsaville BJ; Babor TF; Spitzer RL; Williams JB
    Br J Psychiatry; 1987 Dec; 151():834-43. PubMed ID: 2901887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Lynskey MT; Agrawal A
    Psychol Med; 2007 Sep; 37(9):1345-55. PubMed ID: 17407621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the Diagnostic Interview Schedule in drug-dependent patients.
    Griffin ML; Weiss RD; Mirin SM; Wilson H; Bouchard-Voelk B
    Am J Drug Alcohol Abuse; 1987; 13(3):281-91. PubMed ID: 3687891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement between DSM-III and III-R substance use disorders.
    Cottler LB; Helzer JE; Mager D; Spitznagel EL; Compton WM
    Drug Alcohol Depend; 1991 Dec; 29(1):17-25. PubMed ID: 1797516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reclassifying DIS-III-R alcohol use disorders to DSM-IV criteria in a sample of convicted impaired drivers.
    C'de Baca J; McMillan GP; Lapham SC
    J Stud Alcohol; 2006 Nov; 67(6):898-903. PubMed ID: 17061007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network.
    Forman RF; Svikis D; Montoya ID; Blaine J
    J Subst Abuse Treat; 2004 Jul; 27(1):1-8. PubMed ID: 15223087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of psychiatric disorders in Edmonton. Drug abuse and dependence.
    Russell JM; Newman SC; Bland RC
    Acta Psychiatr Scand Suppl; 1994; 376():54-62. PubMed ID: 8178686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microcomputerized Diagnostic Interview Schedule: clinical use in an out-patient setting.
    Wyndowe J
    Can J Psychiatry; 1987 Mar; 32(2):93-9. PubMed ID: 3552198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore.
    Anthony JC; Folstein M; Romanoski AJ; Von Korff MR; Nestadt GR; Chahal R; Merchant A; Brown CH; Shapiro S; Kramer M
    Arch Gen Psychiatry; 1985 Jul; 42(7):667-75. PubMed ID: 4015308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of the KMSK scales, rapid dimensional measures of self-exposure to specific drugs: Gender-specific features.
    Butelman ER; Chen CY; Fry RS; Kimani R; Levran O; Ott J; Correa da Rosa J; Kreek MJ
    Drug Alcohol Depend; 2018 Sep; 190():179-187. PubMed ID: 30041093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.